Arax Advisory Partners’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.27M Buy
168,022
+143,597
+588% +$2.13M 0.02% 796
2026
Q1
$376K Sell
24,425
-142,057
-85% -$2.37M 0.01% 756
2025
Q4
$3M Sell
166,482
-33,597
-17% -$578K 0.09% 180
2025
Q3
$3.22M Buy
+200,079
New +$2.93M 0.05% 342

Other funds holding MESO

Arax Advisory Partners's MESO Position: Q2 2026 in Review

Arax Advisory Partners increased its Mesoblast (MESO) stake by 588% in Q2 2026, buying an estimated $2.13M and bringing the position to 168,022 shares worth $2.27M. The position accounts for 0.02% of the portfolio, ranked #796.

Arax Advisory Partners first reported a position in MESO in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.22M in Q3 2025. 71 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • Arax Advisory Partners held 168,022 shares of Mesoblast worth $2.27M as of Q2 2026.
  • Arax Advisory Partners bought 143,597 Mesoblast shares in Q2 2026, an estimated $2.13M.
  • Mesoblast made up 0.02% of Arax Advisory Partners's portfolio in Q2 2026, its #796 holding.
  • Arax Advisory Partners first reported a position in Mesoblast in Q3 2025 and has held it in 4 quarters since.
  • Arax Advisory Partners's Mesoblast position peaked at $3.22M in Q3 2025.
  • 71 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.